Added a few more shares. I believe earnings will be better then expected.
Wonder if trading indicates a capital raise coming soon? Hoping it goes down a bit more so I can add more. Dyax worth a lot more than its current market cap based on its drug and royalties from phage, so short run fall doesn't really concern me.
Market Cap is a joke, can't agree more. In the past they have diluted with no regard for shareholders, and lately worked that loan to favorable terms.
To raise capital this time? I'd like to believe it would be shareholder friendly and low risk, high reward for underwriter??
The cash on hand is probably close to alarming. But the cash burn should be substantially less and closer to being profitable.
Sorry for the rant...